Devices › Needle, hypodermic, single lumen
Device brand name · Hypodermic single lumen needle
Bd Nano 2nd Gen Pen Needle: medical device reports filed with FDA
788 reports name it, 2019–2024. Manufacturer given most often on reports: Becton Dickinson And. Product code FMI.
- 788
- device reports naming the brand
- 0% of all MAUDE reports · about 117 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 98.5%
- classified as malfunction
- 87.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
788 medical device reports received by FDA name the brand "Bd Nano 2nd Gen Pen Needle" (hypodermic single lumen needle); the manufacturer given most often on reports is Becton Dickinson And; received from October 2019 to March 2024. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.5%) and injury (1.5%); across all needle, hypodermic, single lumen reports (product code FMI) death is recorded in 0.2% and malfunction in 87.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are failure to deliver (53%), complete blockage (8.6%) and break (7.7%). The patient problems coded most often are pain, hyperglycemia and needle stick/puncture. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 39,876 reports carrying product code FMI. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Failure to deliverthe device did not deliver the dose or item | 418 | 53% | 17.5% |
| Complete blockage | 68 | 8.6% | 8.5% |
| Breakthe device broke | 61 | 7.7% | 12.7% |
| Leak/splashthe device leaked | 45 | 5.7% | 8.5% |
| Defective component | 37 | 4.7% | 1.6% |
| Misconnection | 37 | 4.7% | 2.8% |
| Failure to prime | 33 | 4.2% | 0.3% |
| Defective devicethe device was defective | 26 | 3.3% | 2.9% |
| Physical resistance/sticking | 9 | 1.1% | 0.5% |
| Material protrusion/extrusion | 8 | 1% | 1.3% |
| Obstruction of flow | 7 | 0.9% | 0.9% |
| Loose or intermittent connection | 6 | 0.8% | 0.5% |
| Detachment of device or device componentpart of the device came off | 5 | 0.6% | 2.7% |
| Device contamination with chemical or other material | 5 | 0.6% | 5.4% |
| Device markings/labelling problema problem with the device markings or label | 5 | 0.6% | 2.2% |
| Difficult or delayed activation | 5 | 0.6% | 2.1% |
| Mechanical jam | 5 | 0.6% | 0.2% |
| Component misassembled | 4 | 0.5% | 0% |
| Component missing | 4 | 0.5% | 1.1% |
| Material separation | 4 | 0.5% | 1.2% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Painpain, site not specified | 13 | 1.6% |
| Hyperglycemiahigh blood sugar | 12 | 1.5% |
| Needle stick/puncture | 10 | 1.3% |
| Foreign body in patientpart of a device left in the patient | 6 | 0.8% |
| Bruise/contusion | 4 | 0.5% |
| Easy bruising | 4 | 0.5% |
| Hemorrhage/blood loss/bleeding | 4 | 0.5% |
| Skin inflammation/ irritation | 3 | 0.4% |
| Burning sensationa burning feeling | 1 | 0.1% |
| Complaint, ill-defined | 1 | 0.1% |
| Erythemaskin redness | 1 | 0.1% |
| Hematomaa collection of blood under the skin or in tissue | 1 | 0.1% |
| Hypersensitivity/allergic reaction | 1 | 0.1% |
| Hypoglycemialow blood sugar | 1 | 0.1% |
| Skin infection | 1 | 0.1% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Bd Nano 2nd Gen Pen Needle | Product code FMI | All MAUDE reports |
|---|---|---|---|
| Reports | 788 | 39,876 | 26,136,888 |
| Share of that pool | — | 2% | 0% |
| Classified as death, per 1,000 reports | 0 | 2 | 9 |
| Classified as injury | 1.5% | 10.5% | 36.2% |
| Classified as malfunction | 98.5% | 87.6% | 62.3% |
| Filed by the manufacturer | 100% | 92.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code FMI
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Unspecified Bd Pen Needle | 1,820 | 0 | 0.1% |
| BD Vacutainer Eclipse Blood Collection Needle | 2,116 | 627 | 0% |
| Bd Safetyglide Needle | 1,258 | 3 | 0% |
| Bd Precisionglide Needle | 1,229 | 0 | 0% |
| Bd Ultra Fine Pen Needles | 656 | 0 | 0% |
| Pen Ndl 32g 4mm Pro 100 Box 1200 Us | 510 | 9 | 0% |
| BD SafetyGlide | 576 | 127 | 0% |
| Ez-Io Power Driver | 463 | 0 | 2.2% |
| BD Vacutainer Eclipse Blood Collection Needle with Pre-Attached Holder | 423 | 18 | 0% |
| Bd Ultra Fine Pen Needle | 375 | 0 | 0% |
| Bd Safetyglide Needle Only 25 G | 328 | 0 | 0% |
| Unspecified Bd Needle | 327 | 0 | 0% |
| Bd Ultra-Fine Pen Needle | 320 | 0 | 0% |
| Magellan | 330 | 20 | 0% |
| Bd Vacutainer Flashback Blood Collection Needle | 519 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Bd Nano 2nd Gen Pen Needle reports
How many FDA reports name Bd Nano 2nd Gen Pen Needle?
788 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
malfunction (98.5%) and injury (1.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
failure to deliver (53%), complete blockage (8.6%), break (7.7%), leak/splash (5.7%) and defective component (4.7%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Bd Nano 2nd Gen Pen Needle was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.